Evommune Inc (EVMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Sales | 13,000 | 7,000 |
| Gross Profit | 13,000 | 7,000 |
| Operating Expenses | 94,071 | 77,013 |
| Operating Income | -81,071 | -70,013 |
| Other Income | 12,201 | 3,205 |
| Pre-tax Income | -68,870 | -66,808 |
| Net Income Continuous | -68,870 | -66,808 |
| Net Income | $-68,870 | $-66,808 |
| EPS Basic Total Ops | -11.22 | -45.29 |
| EPS Basic Continuous Ops | -11.22 | -44.30 |
| EPS Diluted Total Ops | -11.22 | -45.29 |
| EPS Diluted Continuous Ops | -11.22 | -44.30 |
| EPS Diluted Before Non-Recurring Items | -11.22 | -45.29 |
| EBITDA(a) | $-79,682 | $-68,726 |